|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | |
| A61K 31/517 | |||
| A61K 31/4184 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2925366 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13802815.4 |
| Europos patento paraiškos padavimo data | 2013-11-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/071852 |
| Data | 2013-11-26 |
| (87) | Numeris | WO 2014/085381 |
| Data | 2014-06-05 |
| (30) | Numeris | Data | Šalis |
| 201261731174 P | 2012-11-29 | US | |
| 201261731555 P | 2012-11-30 | US | |
| 201361755520 P | 2013-01-23 | US |
| (72) |
PORTER, Dale, US
EMERY, Caroline, US
TAN, Lujian, US
YERRAMILLI-RAO, Padmaja, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMBINATIONS |
| PHARMACEUTICAL COMBINATIONS |